Approach to fever in the returning traveler

New England Journal of Medicine

Volumn 376, Issue 6, 2017, Pages 548-560

  Thwaites, Guy E ^a,b   Day, Nicholas P J ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; AGE; BACTERIAL COLONIZATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CLINICAL ASSESSMENT TOOL; CLINICAL DECISION MAKING; CLINICAL FEATURE; COMMUNICABLE DISEASE; DENGUE; DIAGNOSTIC APPROACH ROUTE; DISEASE SURVEILLANCE; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEVER; HELP SEEKING BEHAVIOR; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; INFECTION SENSITIVITY; LABORATORY DIAGNOSIS; LIFE THREAT; LOW RISK PATIENT; MALARIA FALCIPARUM; MEDICAL HISTORY; MEDICAL INFORMATION; MELIOIDOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; PATIENT CARE; PATIENT ISOLATION; PRACTICE GUIDELINE; PREVALENCE; PUBLIC HEALTH SERVICE; REVIEW; RICKETTSIA AFRICAE; RICKETTSIOSIS; RISK ASSESSMENT; SCRUB TYPHUS; TRAVEL; VIRAL RESPIRATORY TRACT INFECTION; ZIKA FEVER; BACTERIAL INFECTIONS; COMPLICATION; ENDEMIC DISEASE; FEVER OF UNKNOWN ORIGIN; HEALTH SURVEY; INFECTION; MALARIA, FALCIPARUM; TYPHOID FEVER; VIRUS DISEASES;

BACTERIAL INFECTIONS; DIAGNOSIS; ENDEMIC DISEASES; FEVER OF UNKNOWN ORIGIN; HUMANS; INFECTION; MALARIA, FALCIPARUM; POPULATION SURVEILLANCE; TRAVEL; TYPHOID FEVER; VIRUS DISEASES;

EID: 85012848480     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1508435     Document Type: Review

References (55)

1. Wilson ME, Freedman DO. Etiology of travel-related fever. Curr Opin Infect Dis 2007; 20: 449-53.
2. Hill DR. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med 2000; 7: 259-66.
3. Wilson ME, Weld LH, Boggild A, et al. Fever in returned travelers: Results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007; 44: 1560-8.
4. International tourist arrivals up 4% reach a record 1.2 billion in 2015. Press release of the United Nations World Tourism Organization, January 18, 2016 (http://media.unwto.org/press-release/2016-01-18/international-Tourist-Arrivals-4-reach-record-12-billion-2015).
5. Gautret P, Gaudart J, Leder K, et al. Travel-Associated illness in older adults (>60 y). J Travel Med 2012; 19: 169-77.
6. Molton JS, Tambyah PA, Ang BS, Ling ML, Fisher DA. The global spread of healthcare-Associated multidrug-resistant bacteria: A perspective from Asia. Clin Infect Dis 2013; 56: 1310-8.
7. Nuesch-Inderbinen M, Abgottspon H, Sagesser G, Cernela N, Stephan R. Antimicrobial susceptibility of travel-related Salmonella enterica serovar Typhi isolates detected in Switzerland (2002-2013) and molecular characterization of quinolone resistant isolates. BMC Infect Dis 2015; 15: 212.
8. Marano C, Freedman DO. Global health surveillance and travelers' health. Curr Opin Infect Dis 2009; 22: 423-9.
9. Leder K. Travelers as a sentinel population: use of sentinel networks to inform pretravel and posttravel evaluation. Curr Infect Dis Rep 2009; 11: 51-8.
10. Torresi J, Leder K. Defining infections in international travellers through the GeoSentinel surveillance network. Nat Rev Microbiol 2009; 7: 895-901.
11. Jensenius M, Han PV, Schlagenhauf P, et al. Acute and potentially life-Threatening tropical diseases in western travelers -A GeoSentinel multicenter study, 1996- 2011. Am J Trop Med Hyg 2013; 88: 397-404.
12. Boggild AK, Esposito DH, Kozarsky PE, et al. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: A cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med 2015; 162: 757-64.
13. Schlagenhauf P, Weld L, Goorhuis A, et al. Travel-Associated infection presenting in Europe (2008-12): An analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-Travel consultation. Lancet Infect Dis 2015; 15: 55-64.
14. Brownstein JS, Freifeld CC, Reis BY, Mandl KD. Surveillance Sans Frontieres: Internet-based emerging infectious disease intelligence and the HealthMap project. PLoS Med 2008; 5(7): E151.
15. Brownstein JS, Freifeld CC, Chan EH, et al. Information technology and global surveillance of cases of 2009 H1N1 influenza. N Engl J Med 2010; 362: 1731-5.
16. Ambresin AE, D'Acremont V, Mueller Y, Martin O, Burnand B, Genton B. www. fevertravel.ch: An online study prototype to evaluate the safety and feasibility of computerized guidelines for fever in returning travellers and migrants. Comput Methods Programs Biomed 2007; 85: 19- 31.
17. Mueller Y, D'Acremont V, Ambresin AE, et al. Feasibility and clinical outcomes when using practice guidelines for evaluation of fever in returning travelers and migrants: A validation study. J Travel Med 2014; 21: 169-82.
18. Demeester RP, Bottieau E, Pini A, et al. Prospective multicenter evaluation of the expert system "KABISA TRAVEL" in diagnosing febrile illnesses occurring after a stay in the tropics. J Travel Med 2011; 18: 386-94.
19. Edberg SC. Global Infectious Diseases and Epidemiology Network (GIDEON): A World Wide Web-based program for diagnosis and informatics in infectious diseases. Clin Infect Dis 2005; 40: 123-6.
20. Ross JJ, Shapiro DS. Evaluation of the computer program GIDEON (Global Infectious Disease and Epidemiology Network) for the diagnosis of fever in patients admitted to a medical service. Clin Infect Dis 1998; 26: 766-7.
21. Luo RF, Bartlett JG. Use of the computer program GIDEON at an inpatient infectious diseases consultation service. Clin Infect Dis 2006; 42: 157-8.
22. Kimura M, Sakamoto M, Adachi T, Sagara H. Diagnosis of febrile illnesses in returned travelers using the PC software GIDEON. Travel Med Infect Dis 2005; 3: 157-60.
23. Bottieau E, Moreira J, Clerinx J, Colebunders R, Van Gompel A, Van den Ende J. Evaluation of the GIDEON expert computer program for the diagnosis of imported febrile illnesses. Med Decis Making 2008; 28: 435-42.
24. Gherardin A, Sisson J. Assessing fever in the returned traveller. Aust Prescr 2012; 35: 10-4.
25. Bottieau E, Clerinx J, Schrooten W, et al. Etiology and outcome of fever after a stay in the tropics. Arch Intern Med 2006; 166: 1642-8.
26. O'Brien DP, Leder K, Matchett E, Brown GV, Torresi J. Illness in returned travelers and immigrants/refugees: The 6-year experience of two Australian infectious diseases units. J Travel Med 2006; 13: 145-52.
27. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801-10.
28. Taylor AJ, Paris DH, Newton PN. A Systematic Review of Mortality from Untreated Scrub Typhus (Orientia tsutsugamushi). PLoS Negl Trop Dis 2015; 9(8): E0003971.
29. Kundavaram AP, Jonathan AJ, Nathaniel SD, Varghese GM. Eschar in scrub typhus: A valuable clue to the diagnosis. J Postgrad Med 2013; 59: 177-8.
30. Dondorp A, Nosten F, Stepniewska K, Day N, White N. Artesunate versus quinine for treatment of severe falciparum malaria: A randomised trial. Lancet 2005; 366: 717-25.
31. Dondorp AM, Fanello CI, Hendriksen IC, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): An openlabel, randomised trial. Lancet 2010; 376: 1647-57.
32. Artesunate is available to treat severe malaria in the United States. Atlanta: Centers for Disease Control and Prevention, 2010 (www.cdc.gov/malaria/diagnosis-Treatment/artesunate.html).
33. Kantele A, Laaveri T, Mero S, et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase- producing Enterobacteriaceae. Clin Infect Dis 2015; 60: 837-46.
34. Pitman MC, Luck T, Marshall CS, Anstey NM, Ward L, Currie BJ. Intravenous therapy duration and outcomes in melioidosis: A new treatment paradigm. PLoS Negl Trop Dis 2015; 9(3): E0003586.
35. Rahi M, Gupte MD, Bhargava A, Varghese GM, Arora R. DHR-ICMR guidelines for diagnosis & management of rickettsial diseases in India. Indian J Med Res 2015; 141: 417-22.
36. Ftika L, Maltezou HC. Viral haemorrhagic fevers in healthcare settings. J Hosp Infect 2013; 83: 185-92.
37. Ebola (Ebola virus disease): Epidemiologic risk factors to consider when evaluating a person for exposure to Ebola virus. Atlanta: Centers for Disease Control and Prevention, May 28, 2015 (https://www.cdc.gov/vhf/ebola/exposure/risk-factors-when-evaluating-person-for-exposure.html).
38. Public Health England. Risk assessment of the Ebola virus disease outbreak in West Africa: updated 24 June 2015 (https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/437990/PHE-Risk-Assessment-Update-7-FINAL.pdf).
39. Rogstad KE, Tunbridge A. Ebola virus as a sexually transmitted infection. Curr Opin Infect Dis 2015; 28: 83-5.
40. Nielsen CF, Kidd S, Sillah AR, Davis E, Mermin J, Kilmarx PH. Improving burial practices and cemetery management during an Ebola virus disease epidemic - Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep 2015; 64: 20-7.
41. Public Health England. Viral haemorrhagic fever: ACDP algorithm and guidance on management of patients. November 19, 2015 (https://www.gov.uk/government/publications/viral-haemorrhagic-fever-Algorithm-And-guidance-on-management-of-patients).
42. Hui DS, Zumla A. Emerging respiratory tract viral infections. Curr Opin Pulm Med 2015; 21: 284-92.
43. Ruppe E, Armand-Lefevre L, Estellat C, et al. High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics. Clin Infect Dis 2015; 61: 593-600.
44. van der Bij AK, Pitout JD. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 2012; 67: 2090-100.
45. Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med 2002; 347: 505-16.
46. Johnston V, Stockley JM, Dockrell D, et al. Fever in returned travellers presenting in the United Kingdom: Recommendations for investigation and initial management. J Infect 2009; 59: 1-18.
47. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354: 119-30.
48. Leder K, Tong S, Weld L, et al. Illness in travelers visiting friends and relatives: A review of the GeoSentinel Surveillance Network. Clin Infect Dis 2006; 43: 1185-93.
49. Matteelli A, Schlagenhauf P, Carvalho AC, et al. Travel-Associated sexually transmitted infections: An observational crosssectional study of the GeoSentinel surveillance database. Lancet Infect Dis 2013; 13: 205-13.
50. Lim PL, Han P, Chen LH, et al. Expatriates ill after travel: Results from the Geosentinel Surveillance Network. BMC Infect Dis 2012; 12: 386.
51. Hagmann S, Neugebauer R, Schwartz E, et al. Illness in children after international travel: Analysis from the GeoSentinel Surveillance Network. Pediatrics 2010; 125(5): E1072-e1080.
52. Schlagenhauf P, Chen LH, Wilson ME, et al. Sex and gender differences in travelassociated disease. Clin Infect Dis 2010; 50: 826-32.
53. Boggild AK, Castelli F, Gautret P, et al. Vaccine preventable diseases in returned international travelers: Results from the GeoSentinel Surveillance Network. Vaccine 2010; 28: 7389-95.
54. Moulin E, Selby K, Cherpillod P, Kaiser L, Boillat-Blanco N. Simultaneous outbreaks of dengue, chikungunya and Zika virus infections: diagnosis challenge in a returning traveller with nonspecific febrile illness. New Microbes New Infect 2016; 11: 6-7.
55. Wikan N, Smith DR. Zika virus: history of a newly emerging arbovirus. Lancet Infect Dis 2016; 16(7): E119-e126.